Clinical Trial Update: Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update indicating the NT-0796 study in obese participants at risk of cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• NT-0796

Snippet

Sponsor: NodThera Limited | Conditions: Cardiovascular Diseases | Phase 1 | Status: COMPLETED